Takeda

Samsung Bioepis and Takeda begin first trial from R&D tie-up

https://pharmaphorum.com/news/samsung-bioepis-and-takeda-begin-first-trial-from-rd-tie-up/

Takeda finalises buyout of TiGenix

https://pharmaphorum.com/news/japanese-takeda-finalises-tigenix-boyout/

J&J tops the pharma market cap charts – but for how long?

https://pharmaphorum.com/views-and-analysis/jj-tops-pharma-market-cap-charts-long/

Forendo joins race to develop endometriosis drugs

https://pharmaphorum.com/news/forendo-joins-race-to-develop-endometriosis-drugs/

Roche haemophilia data piles pressure on Shire

https://pharmaphorum.com/news/roche-haemophilia-data-piles-pressure-on-shire/

Takeda to cut IT, marketing and sales jobs after Shire merger

https://pharmaphorum.com/news/takeda-to-cut-it-marketing-and-sales-jobs-after-shire-merger/

Takeda takes biggest gamble of 2018 with Shire merger

https://pharmaphorum.com/news/takeda-biggest-gamble-of-2018-with-shire-merger/

Shire recommends Takeda’s £46bn bid

https://pharmaphorum.com/news/shire-recommends-takedas-46bn-bid/

Takeda woos Shire shareholders with increased bid

https://pharmaphorum.com/news/takeda-woos-shire-shareholders-with-increased-bid/

1 2 3 4 5 >»

Close in 10 seconds

Pharmaphorum.com

Search